Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/1999

01-12-1999 | Paper Report

Epstein-Barr virus in breast cancers

Author: Chris Jones

Published in: Breast Cancer Research | Issue 1/1999

Login to get access

Excerpt

The Epstein-Barr Virus (EBV) is associated with the development of a range of different human cancers, including several types of carcinoma. A correlation between EBV-associated lymphomas and a high incidence of male breast cancer has been reported, and furthermore, EBV-associated lymphomas have been reported to be localized in the breast. Two studies have detected EBV in 20-40% of breast tumors investigated. These observations have led some investigators to suggest that the virus may play a role in the development of breast cancer. …
Literature
1.
Bonnet M, Guinebretiere J-M, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I: Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst. 1999, 91: 1376-1381.CrossRefPubMed
Metadata
Title
Epstein-Barr virus in breast cancers
Author
Chris Jones
Publication date
01-12-1999
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/1999
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-1999-66607

Other articles of this Issue 1/1999

Breast Cancer Research 1/1999 Go to the issue

Web Report

Break IT - The Breast Cancer Pathology Information Kit

Paper Report

Pathologic findings from the NSABP B-17 protocol: 8 year update

Paper Report

Role of the mitotic checkpoint in transformation of Brca2 null cells

Paper Report

Risk of breast cancer in women with palpable breast cysts

Paper Report

17q aberrations in breast cancer

Paper Report

PTEN Immunohistochemistry in Breast Carcinoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits